Cotrimoxazole is generally used to manage Pneumocystis jiroveci pneumonia in children receiving chemotherapy


    loading  Checking for direct PDF access through Ovid

Abstract

Paediatric patients undergoing chemotherapy are at risk of developing pneumonia (PCP) and should receive PCP prophylaxis. Cotrimoxazole (trimethoprim-sulfamethoxazole) is the drug of choice for prophylaxis and treatment

    loading  Loading Related Articles